The Central Drugs Standard Control Organisation (CDSCO) has highlighted the importance of responsible use of medicines, particularly painkillers and antibiotics, amid concerns over the potential impact of inappropriate or prolonged medication use on kidney health. The advice is aimed at encouraging patients to use medicines only when necessary and under appropriate medical guidance.
Commonly used painkillers, particularly non-steroidal anti-inflammatory drugs (NSAIDs), can affect kidney function in some circumstances. The risk can be higher when such medicines are taken frequently, in excessive doses or by people who already have kidney problems, dehydration or certain other medical conditions.
Antibiotics are also important medicines that should be used appropriately. Unnecessary or inappropriate antibiotic use can contribute to antimicrobial resistance and may also cause adverse effects. Health authorities therefore advise patients not to self-medicate with antibiotics or use leftover medicines without medical advice.
CDSCO’s recent regulatory activity includes recommendations from its specialist committees covering both antimicrobial medicines and nephrology and urology. The agency’s September 2026 records show recent meetings and recommendations in these areas.
Medical professionals generally recommend that patients inform their doctors about existing kidney disease, other medicines they are taking and any history of medication-related complications before starting treatment. Adequate hydration and appropriate monitoring may also be important for people who require certain medicines for extended periods.
The advisory message reinforces the importance of avoiding self-medication and following the prescribed dose and duration of treatment. Patients should consult a qualified healthcare professional if they experience symptoms such as reduced urine output, swelling, unusual fatigue or other concerning symptoms while taking medicines.
The CDSCO, India’s national regulatory authority for drugs and medical products, operates under the Directorate General of Health Services, Ministry of Health and Family Welfare. Its responsibilities include regulating the safety, quality and standards of medicines in the country.
